Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 billion… Read More
